Next Article in Journal
Hepatobiliary Adverse Events Associated with Pembrolizumab: A Pharmacovigilance Study from the FDA Adverse Event Reporting System (FAERS) Database
Previous Article in Journal
Assessment of the Utilization of Sodium–Glucose Cotransporter-2 Inhibitors in Patients Without Diabetes
 
 
Case Report

Article Versions Notes

Pharmacoepidemiology 2024, 3(4), 394-402; https://doi.org/10.3390/pharma3040028
Action Date Notes Link
article xml file uploaded 11 December 2024 08:11 CET Original file -
article xml uploaded. 11 December 2024 08:11 CET Update https://www.mdpi.com/2813-0618/3/4/28/xml
article pdf uploaded. 11 December 2024 08:11 CET Version of Record https://www.mdpi.com/2813-0618/3/4/28/pdf
article html file updated 11 December 2024 08:12 CET Original file https://www.mdpi.com/2813-0618/3/4/28/html
Back to TopTop